Amplitude Ventures

Amplitude Ventures invests in life sciences and biotechnology companies, bringing healthcare innovations to market to help improve the lives of patients. Its Fund II will focus on early-stage companies in the areas of high value therapies, medical technology, and artificial intelligence and machine learning.

“Vancouver is rapidly expanding as a global biotechnology sector. Amplitude has been a key part of this growth as we invest to leverage B.C.’s leading innovation in targeted and cellular therapies. InBC’s investment is key to enable Amplitude to catalyze the capital necessary for the growth of the sector.”

— Ali Tehrani, Partner, Amplitude Ventures

Established
2018

Aligned impact objective
Innovating for the future

Purpose
To bring healthcare innovations to market to help improve the lives of patients

InBC commitment amount
Fund II: $10 million

Year invested
2023